Esophageal basaloid squamous cell carcinoma (EBSCC) is a rare type of esophageal squamous cell cancer (ESCC) characterized by basaloid features and considered to be more aggressive than ESCC. RNA ...

A phase 1 clinical trial is now open for enrollment to patients with high-grade neuroendocrine tumors to receive treatment ...

One of these is ozuriftamab vedotin, a CAB-ROR2 ADC in a phase 2 trial for HPV-positive squamous cell carcinoma of the head and neck. This population is “poorly served” by EGFR inhibitors ...

metastatic HPV-positive squamous cell carcinoma of the head and neck (SCCHN); a population which is poorly served by EGFR inhibitors Cash balance of $49mm at year-end 2024 with recent cost ...

Autopsy demonstrated extensive metastatic carcinoma of the endometrium ... showed the tumor to be quite similar and rather poorly differentiated. Case 5. M.J. (M.G.H. 1009968), a 67-year-old ...

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

Sarah Burris is a long-time veteran of political campaigns, having worked as a fundraiser and media director across the United States. She transitioned into reporting while working for Rock the ...

EMR is indicated for superficial, well-differentiated and/or moderately differentiated squamous cell carcinoma that is limited to the lamina propria. One of the newer ablative techniques is low ...

However, its specific role in gastric adenocarcinoma—the most common form of stomach cancer—remains unclear, with inconsistent findings across studies. To address this uncertainty, researchers ...